The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
Intestinal PermeabilityGastrointestinal IrritationMucositis
Interventions
DIETARY_SUPPLEMENT

Probiotic

Probiotics (beneficial microorganisms) VSL#3 is a probiotic formula containing a mixture of 9x10\^10 CFU/g Lactobacilli strains (Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, and Lactobacillus bulgaricus), 8x10\^10 CFU/g Bifidum strains (Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis) and 20x10\^10 CFU/g Streptococcus thermophilus

Trial Locations (1)

2100 OE

Departmen of Oncology, Rigshospital, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Actial Farmaceutica S.r.l.

INDUSTRY

collaborator

Nutricia, Inc.

INDUSTRY

lead

University of Copenhagen

OTHER